interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development
EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).
The EU Clinical Trials Register currently displays
44335
clinical trials with a EudraCT protocol, of which
7366
are clinical trials conducted with subjects less than 18 years old.
The register also displays information on
18700
older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).
Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see
Frequently Asked Questions ).
4 result(s) found for: Delayed sleep phase disorder.
Displaying page 1 of 1.
EudraCT Number: 2021-005475-40
Sponsor Protocol Number: VP-VEC-162-3502
Start Date*: 2022-06-08
Sponsor Name:Vanda Pharmaceuticals Inc.
Full Title: A multicenter, double-blind, randomized study to evaluate the effects of tasimelteon vs. placebo in participants with Delayed Sleep-Wake Phase Disorder (DSWPD)
Medical condition: Delayed Sleep-Wake Phase Disorder (DSWPD)
Disease:
Version
SOC Term
Classification Code
Term
Level
21.0
10029205 - Nervous system disorders
10041013
Sleep-wake schedule disorder
LLT
Population Age: Adults, Elderly
Gender: Male, Female
Trial protocol:DE(Trial now transitioned)AT(Trial now transitioned)
Trial results:(No results available)
EudraCT Number: 2012-000320-18
Sponsor Protocol Number: FASE01
Start Date*: 2012-11-22
Sponsor Name:Parnassia Bavo Groep - PsyQ
Full Title: Phase shift in adult ADHD of sleep and apetite.
Medical condition: Delayed Sleep Phase Syndrome (DSPS) in adult patients with Attention-Deficit/Hyperctivity Disorder (ADHD)
Sponsor Name:Takeda Development Center Americas, Inc.
Full Title: A Phase 4, Multicenter, 2-part Study Composed of a 1-Year Randomized,
Double-blind, Parallel-group, Placebo-controlled, Active-comparator,
Dose-optimization Evaluation followed by a 1-Year Open-lab...
Medical condition: Attention-deficit/hyperactivity disorder (ADHD)
Disease:
Version
SOC Term
Classification Code
Term
Level
23.0
100000004873
10064104
ADHD
LLT
Population Age: Children, Adolescents, Under 18
Gender: Male, Female
Trial protocol:DE(Ongoing)NL(Trial now transitioned)SE(Trial now transitioned)AT(Prematurely Ended)ES(Ongoing)BE(Trial now transitioned)PT(Prematurely Ended)GB(GB - no longer in EU/EEA)
Trial results:(No results available)
EudraCT Number: 2020-006067-28
Sponsor Protocol Number: CST103/CST107-CLIN-011
Start Date*: 2022-01-10
Sponsor Name:CuraSen Therapeutics, Inc.
Full Title: A Phase II, Randomized, Placebo-Controlled, Double-Blind, Crossover, Study of the Pharmacodynamic Effects of CST-103 co-administered with CST-107 on the Central Nervous System in Subjects with Neur...
Medical condition: Patients with Parkinson’s Disease with REM sleep behaviour disorder, Mild Cognitive Impairment, Dementia with Lewy Bodies and Parkinson’s Disease Dementia.
Subscribe to this Search
To subscribe to the RSS feed for this search click
here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options:
Number of Trials to download:
Download Content:
Download Format:
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
• EEA CTAs: Date study was authorised to proceed • Outside EU/EEA: Date study was submitted in EudraCT
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Query did not match any studies.
